ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers with gene mutations
Disease control OngoingThis early-phase study tests a new drug (AZD8186) combined with chemotherapy (docetaxel) in people with advanced solid tumors that have certain gene changes (PTEN or PIK3CB mutations). The main goals are to find the safest dose and understand side effects. About 23 adults whose c…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC
-
New web tool aims to ease life for young breast cancer survivors
Symptom relief OngoingThis study tests a web-based tool called YES that helps young breast cancer survivors track and manage their symptoms. About 400 women aged 15-39 who had early-stage breast cancer in the last 3 years are taking part. The goal is to see if using the YES portal improves their quali…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 29, 2026 01:35 UTC
-
Walking through chemo: new study tests exercise in older breast cancer patients
Symptom relief OngoingThis study looks at whether a regular exercise program is practical for women aged 65 and older who are receiving chemotherapy for early-stage breast cancer. Participants will be asked to walk and do arm exercises several times a week during their treatment. The goal is to see if…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 29, 2026 01:34 UTC
-
Gene test may predict chemo nerve pain in black breast cancer patients
Knowledge-focused OngoingThis study tests whether a genetic marker can identify African American women with breast cancer who are at higher risk for nerve damage from chemotherapy drugs like Taxol or Taxotere. About 249 women with stage I-III breast cancer will be followed to see how their genes affect n…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:37 UTC
-
Gene test may match breast cancer patients to right therapy
Knowledge-focused OngoingThis study looks at whether genetic testing of tumor samples can help predict how well chemotherapy or hormone therapy will work for people with HER2-negative breast cancer (stages I to III). Researchers will analyze tumor genes to see if they can sort patients into groups that a…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:35 UTC